The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis

The Ottawa score (OS) for predicting the risk of recurrent venous thromboembolism (VTE) in cancer patients with VTE may help to guide anticoagulant treatment decisions that will optimize benefit-risk ratios. However, data on its reliability are conflicting. We applied the OS to all cancer patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Frere, Corinne, Crichi, Benjamin, Wahl, Clémentine, Lesteven, Elodie, Connault, Jérôme, Durant, Cécile, Rueda-Camino, Jose Antonio, Yannoutos, Alexandra, Bensaoula, Okba, Le Maignan, Christine, Marjanovic, Zora, Farge, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267563/
https://www.ncbi.nlm.nih.gov/pubmed/35807014
http://dx.doi.org/10.3390/jcm11133729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267563/
https://www.ncbi.nlm.nih.gov/pubmed/35807014
http://dx.doi.org/10.3390/jcm11133729

Ejemplares similares